Microdosing is the practice of taking small, sub-perceptual doses of psychedelic substances, such as LSD (lysergic acid diethylamide), psilocybin (found in "magic mushrooms"), or DMT (dimethyltryptamine), with the goal of improving physical, emotional, and cognitive well-being.
The idea behind microdosing is that these substances can have positive effects on mood, creativity, and productivity, without inducing the full-blown psychedelic experience. Microdosing typically involves taking a dose that is too small to cause noticeable changes in perception or thought patterns, but is thought to have subtle effects on mood and behavior.
People who engage in microdosing report a variety of benefits, including increased energy, focus, and creativity, as well as reduced anxiety and depression. However, it's important to note that there is limited scientific evidence to support these claims, and the long-term effects of microdosing are not well understood.
Additionally, it is important to note that psychedelic substances are illegal in many countries and can have serious side effects, including hallucinations, anxiety, and paranoia. It is also not recommended to self-medicate with these substances, and individuals should consult with a qualified healthcare professional before starting any new treatment, including microdosing.
There are several experts who have written about microdosing protocols and the benefits and risks associated with this practice. Here are a few notable authors:
James Fadiman, PhD: James Fadiman is a psychologist and researcher who has written extensively about the benefits of microdosing. He is the author of "The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys."
Dr. James Oroc: Dr. James Oroc is a researcher and author who has written about the science behind microdosing and its potential benefits. He is the author of "Tryptamine Palace: 5-MeO-DMT and the Sonoran Desert Toad."
Paul Austin: Paul Austin is a writer and speaker who has written about his personal experiences with microdosing and its effects on his life and work. He is the founder of The Third Wave, a company that provides resources and information about microdosing.
Dr. Rick Doblin: Dr. Rick Doblin is a psychologist and founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), an organization dedicated to the study and use of psychedelics in therapy. He has written about the potential benefits of microdosing and the need for further research in this area.
These experts have written about the protocols, benefits, and risks associated with microdosing, and can provide valuable insights for individuals interested in exploring this practice.